Kueffer, Thomas
Stefanova, Anita
Madaffari, Antonio
Seiler, Jens
Thalmann, Gregor
Kozhuharov, Nikola
Maurhofer, Jens
Galuszka, Oskar
Haeberlin, Andreas
Noti, Fabian
Servatius, Helge
Tanner, Hildegard
Roten, Laurent
Reichlin, Tobias http://orcid.org/0000-0002-7197-8415
Funding for this research was provided by:
University of Bern
Article History
Received: 25 May 2023
Accepted: 12 July 2023
First Online: 31 July 2023
Change Date: 23 February 2024
Change Type: Update
Change Details: Springer Nature’s version of this paper was updated to reflect the missing Supplementary data.
Declarations
:
: A. Haeberlin: Research grants from the Swiss National Science Foundation, Innosuisse, the Swiss Heart Foundation, the University of Bern, the University Hospital Bern, the Velux Foundation, the Hasler Foundation, the Swiss Heart Rhythm Foundation, and the Novartis Research Foundation. He is Co-founder and CEO of Act-Inno, a cardiovascular device testing company. He has received travel fees/educational grants from Medtronic, Philips/Spectranetics and Cairdac without impact on his personal remuneration.L. Roten: speaker honoraria from Abbott/SJM, consulting honoraria from Medtronic and research grant to the institution from Medtronic.T. Reichlin: Research grants from the Goldschmidt-Jacobson Foundation, the Swiss National Science Foundation, the Swiss Heart Foundation, the European Union [Eurostars 9799 – ALVALE) and the Professor Max Cloëtta Foundation, all for work outside the submitted study. Speaker/consulting honoraria or travel support from Abbott/SJM, Astra Zeneca, Brahms, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Medtronic, Pfizer-BMS and Roche, all for work outside the submitted study. Support for his institution’s fellowship program from Abbott/SJM, Biosense-Webster, Biotronik, Boston-Scientific and Medtronic for work outside the submitted study.F. Noti: Medtronic, Abbott: Travel fees, speaker fees, educational grant; Boston Scientific, Philips Spectranetics: Travel fees, educational grant; Biotronik: Institutional grant all for work outside the submitted study.J: Seiler: The spouse of Dr Seiler is an employee of Boston Scientific and stock owner of Boston Scientific and Abbott.All other authors report no conflicts of interest related to this paper.